| 6/27/2007 | CV | MedImmune calls 1% convertibles
|
| 6/18/2007 | CV | MedImmune closes merger, says 1.375%, 1.625% notes convertible through July 31
|
| 5/2/2007 | CV | MedImmune says upcoming acquisition makes 1.375%, 1.625% notes convertible
|
| 4/30/2007 | CV | Market Commentary: Tyco continues gains amid tender offer; MedImmune up ahead of earnings; issuance grows in April
|
| 4/23/2007 | CV | Market Commentary: MedImmune surges on buyout; Bausch & Lomb climbs on rumors; AMD, Charming Shoppes launch deals
|
| 4/12/2007 | CV | Market Commentary: TriZetto gains in start; MedImmune surges on buyer search; RAIT, Franklin deals seen with subprime risks
|
| 7/28/2006 | BTCV | MedImmune 1% noteholders opt to put $489.6 million notes in July
|
| 6/28/2006 | BTCV | MedImmune greenshoes fully exercised, boosting convertibles sales to $1.15 billion
|
| 6/27/2006 | CV | Market Commentary: MedImmune, Gilead trade; Vector launches overnight deal; Chesapeake prices
|
| 6/23/2006 | BTCV | New Issue: MedImmune $1 bln convertibles: five year yields 1.375%, seven year yields 1.625%, up 22.5%
|
| 6/22/2006 | CV | Market Commentary: MedImmune on deck, no gray seen; Equity Office Properties, American Medical new deals seen higher
|
| 6/22/2006 | BTCV | MedImmune prices $1 billion convertibles: 5-years yield 1.375%, 7-years yield 1.625%, both up 22.5%
|
| 6/22/2006 | BTCV | S&P gives MedImmune convertibles BBB
|
| 6/21/2006 | CV | Market Commentary: Teva sinks outright, holds up dollar neutral; Group 1 re-offered; $2 billion new deals seen pricing Thursday
|
| 6/21/2006 | BTCV | MedImmune launches $1 billion of convertibles in two tranches
|
| 1/18/2006 | CV | Market Commentary: Techs dominate convertibles market; Intel drops outright but expands on a hedged basis, AMD adds
|
| 12/12/2005 | CV | Market Commentary: Intel launches $1.4 billion convertible offering; Omnicare to price; MedImmune edges up
|
| 11/15/2005 | CV | Market Commentary: Ford, GM, oil and gas, airlines down; EDO shows up in the gray; Pantry, C&D, E*Trade deals ahead
|
| 10/12/2004 | CV | Market Commentary: Apex Silver hovers around par; Amkor firms as bids hit; NPS Pharma, biotechs suffer
|
| 10/5/2004 | CV | Market Commentary: General Mills issue rises; Chiron, Henry Schein fall on flu scare but MedImmune gains
|
| 4/30/2004 | CV | S&P rates MedImmune converts BBB
|
| 2/3/2004 | CV | Goldman Sachs prices $10 million 4.875% notes exchangeable for MedImmune
|
| 12/16/2003 | CV | Market Commentary: Four deals to price after the close Tuesday; Mentor adds $125 million overnighter
|
| 10/17/2003 | CV | Market Commentary: XL holds up against stock slide on warning, boost to reserves; new Getronics euro issue zooms
|
| 7/11/2003 | CV | Market Commentary: Charter deal emerges as junk bond to fund tender for its convertibles, which climb further
|
| 7/10/2003 | CV | New Issue: MedImmune $500 million convertibles yield 1.0%, up 75%
|
| 7/10/2003 | CV | Market Commentary: CMS ponies up more yield; MedImmune repriced at 95; buzz emerges of Charter deal
|
| 7/9/2003 | CV | Market Commentary: CMS deal revived with wider yield talk, joining TXU after close as power issues heat up
|
| 7/9/2003 | CV | MedImmune $500 million convertible talked at 0.5-1.0% yield, up 75%
|
| 1/30/2003 | CV | Market Commentary: Micron trading lighter as outright buyers hold on; several drug issues gain
|
| 9/12/2002 | CV | Market Commentary: Market bolstered by tightening credit spreads as stocks decline
|
| 7/10/2002 | CV | Market Commentary: Stock plunge, earnings worries sideline players, pressure prices
|
| 4/10/2002 | CV | Market Commentary: Duane Reade brings new deal in new structure; Biotechs, drugs higher on short covering
|
| 4/5/2002 | CV | Market Commentary: Adelphia gains on hiring advisors; Getty Images soars on EPS revision; Genentech falls
|
| 12/7/2001 | CV | Market Commentary: Convertible market slides as stock enthusiasm withers, no new deals
|
| 12/4/2001 | CV | Market Commentary: Convertible market moves higher, gets spate of new deals lineup
|
| 12/3/2001 | CV | Convertible market pulls back modestly as stocks lose on Enron bankruptcy
|
